BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 15555620)

  • 1. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
    Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
    J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model.
    Tan J; Newton CA; Djeu JY; Gutsch DE; Chang AE; Yang NS; Klein TW; Hua Y
    Cancer Res; 1996 Aug; 56(15):3399-403. PubMed ID: 8758901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production.
    Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH
    J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.
    Siders WM; Wright PW; Hixon JA; Alvord WG; Back TC; Wiltrout RH; Fenton RG
    J Immunol; 1998 Jun; 160(11):5465-74. PubMed ID: 9605149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
    Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
    Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-gamma-stimulated defense.
    Rushfeldt C; Sveinbjørnsson B; Seljelid R; Smedsrød B
    J Surg Res; 1999 Apr; 82(2):209-15. PubMed ID: 10090831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA.
    Schultz J; Heinzerling L; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 Dec; 7(12):1557-65. PubMed ID: 11228534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
    Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
    J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
    Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
    J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
    Takahashi M; Ogasawara K; Takeda K; Hashimoto W; Sakihara H; Kumagai K; Anzai R; Satoh M; Seki S
    J Immunol; 1996 Apr; 156(7):2436-42. PubMed ID: 8786302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLT3-ligand administration inhibits liver metastases: role of NK cells.
    Péron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
    J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.